Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,781 | -5,269 | -13,019 | -11,047 | -8,684 |
| Depreciation Amortization | 113 | 48 | 69 | 53 | 35 |
| Accounts payable and accrued liabilities | 958 | 805 | N/A | N/A | N/A |
| Other Working Capital | 1,095 | -1,417 | -4,494 | -3,444 | -2,582 |
| Other Operating Activity | 73 | -236 | 1,188 | 1,072 | 988 |
| Operating Cash Flow | $-9,542 | $-6,069 | $-16,255 | $-13,366 | $-10,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 3 | N/A | N/A |
| Net Acquisitions | 250 | 250 | N/A | N/A | N/A |
| Investing Cash Flow | $250 | $250 | $3 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -9,514 | -9,514 | -5,514 |
| Common Stock Issued | N/A | N/A | 34 | 34 | 19 |
| Other Financing Activity | -648 | -580 | -538 | -538 | -538 |
| Financing Cash Flow | $-648 | $-580 | $-10,019 | $-10,019 | $-6,034 |
| Beginning Cash Position | 11,487 | 11,487 | 37,949 | 37,949 | 37,949 |
| End Cash Position | 1,547 | 5,088 | 11,678 | 14,564 | 21,672 |
| Net Cash Flow | $-9,940 | $-6,399 | $-26,271 | $-23,385 | $-16,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,542 | -6,069 | -16,255 | -13,366 | -10,243 |
| Free Cash Flow | -9,542 | -6,069 | -16,255 | -13,366 | -10,243 |